EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC 4.0

On the Concepts, Methods, and Use of “Probability of Success” for Drug Development Decision‐Making: A Scoping Review

Aysun Cetinyurek Yavuz iD, Muhammad Bergas Nur Fayyad iD, Ce Jiang iD, Florie Brion Bouvier, Celine Beji, Sonia Zebachi iD, Ghinwa Y Hayek iD, Billy Amzal, Raphael Porcher iD, Julien Tanniou iD, Kit Roes iD, Laura Rodwell iD

Clinical Pharmacology & Therapeutics · 2025

DOI: 10.1002/cpt.3571 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Aysun Cetinyurek Yavuz und 11 weiteren Autor:innen. Beteiligte Einrichtung: IQ Health Department, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Drug Development, Decision Making, Clinical Trials, Phase III as Topic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug development is a lengthy process with considerable uncertainty at each milestone. Several trials are needed to progress to confirmatory evaluation and establish a positive benefit–risk balance. One of the critical milestones is the decision to progress to phase III based on phase II trial results. Use of probability of success is becoming standard in pharmaceutical companies to support this decision. However, the lack of consistency in terminology makes it difficult to assess the comparative value of different approaches. By leveraging the availability of high‐quality external data (e.g., real‐world data, historical clinical trial data, etc.), probability of success‐based procedures may further improve decision‐making. We performed a scoping review of approaches to calculate the probability of success of a phase III trial depending on the available data sources and the availability of specific endpoints. Calculation of probability of success is relatively straightforward if data for the primary endpoint of the phase III trial are also available in phase II trials. Often, phase II trials are based on biomarker or surrogate outcomes, due to challenges associated with study duration and required sample size. Probability of success‐based procedures as reviewed can incorporate external data sources, for example, from clinical trials testing the same or similar drug or real‐world data on the targeted population—optimizing the calculation of probability of trial success and the projected drug candidate value. We conclude the paper by reflecting on alternative approaches and ideas for uses within pharmaceutical companies and academia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DevelopmentDecision MakingClinical Trials, Phase III as TopicHumansClinical Trials, Phase II as TopicProbabilityResearch Design

Autor:innen und Institutionen

  • IQ Health Department, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Quinten Health, Paris, France.
  • Paris Cité University, Paris, France.

ORCID-Profile: Aysun Cetinyurek Yavuz, Muhammad Bergas Nur Fayyad, Ce Jiang, Sonia Zebachi, Ghinwa Y Hayek, Raphael Porcher, Julien Tanniou, Kit Roes, Laura Rodwell

Zitieren

APA

Cetinyurek Yavuz, A., Fayyad, M. B. N., Jiang, C., Brion Bouvier, F., Beji, C., Zebachi, S., Hayek, G. Y., Amzal, B., Porcher, R., Tanniou, J., Roes, K., & Rodwell, L. (2025). On the Concepts, Methods, and Use of “Probability of Success” for Drug Development Decision‐Making: A Scoping Review. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3571

Vancouver

Cetinyurek Yavuz A, Fayyad MBN, Jiang C, Brion Bouvier F, Beji C, Zebachi S, et al. On the Concepts, Methods, and Use of “Probability of Success” for Drug Development Decision‐Making: A Scoping Review. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.3571

BibTeX
@article{CetinyurekYavuz2025,
  author = {Cetinyurek Yavuz, Aysun and Fayyad, Muhammad Bergas Nur and Jiang, Ce and Brion Bouvier, Florie and Beji, Celine and Zebachi, Sonia and Hayek, Ghinwa Y and Amzal, Billy and Porcher, Raphael and Tanniou, Julien and Roes, Kit and Rodwell, Laura},
  title = {On the Concepts, Methods, and Use of “Probability of Success” for Drug Development Decision‐Making: A Scoping Review},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1002/cpt.3571}
}
Kostenlos starten →